PDLIM7 and diffuse large B-cell lymphoma: Latency III program is prevalent, since viral oncogenic antigens EBERs, LMP1, and EBNA-2 are positive in most cases, which may be related to the pathogenesis of this particular DLBCL subtype [44,111].